 |
PDBsum entry 1itf
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
274:661-675
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution.
|
|
W.Klaus,
B.Gsell,
A.M.Labhardt,
B.Wipf,
H.Senn.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The solution structure of recombinant human interferon alpha-2a (Roferon-A) has
been determined by multidimensional heteronuclear NMR spectroscopy. The
calculations using simulated annealing produced a family of 24 convergent
structures which satisfy the experimental restraints comprising 1541 NOE-derived
inter-proton distances, 187 dihedral restraints, 66 pairs of hydrogen bond
restraints, and six upper and lower limits for two disulfide bridges. The
fractional labeling of methyl groups allowed their direct and unambiguous
stereospecific assignment which proved to be essential for obtaining a high
resolution of the structures. A best fit superposition of residues 10 to 47, 50
to 101 and 111 to 157 gives an rms deviation of 0.62 A for the backbone heavy
atoms and 1.39 A for all heavy atoms of these segments. The dominant feature of
the structure is a cluster of five alpha-helices, four of which are arranged to
form a left-handed helix bundle with an up-up-down-down topology and two
over-hand connections. The interpretation of heteronuclear 15N-¿1H¿ NOE data
shows the co-existence of flexible regions within an otherwise rigid framework
of the protein. Four stretches of pronounced flexibility can be located:
Cys1-Ser8, Gly44-Ala50, Ile100-Lys112, and Ser160-Glu165. Among the structurally
related four-helical bundle cytokines, the structure of IFN alpha-2a is most
similar to that of human interferon alpha-2b and murine interferon-beta. From
this structural information and mutagenesis data, areas on the surface of the
protein are identified which seem to be important in receptor interactions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Overlay of the side-chains of the well-defined
amino acids of the final structures together with the
polypeptide backbones (in yellow). The side-chains are colored
according to residue type: Asp, Glu: red; Arg, Lys: dark blue;
Ala, Ile, Leu, Phe, Val: cyan; Pro, Trp: green; Thr, Tyr, Ser:
white. The flexible loops are clustered at the top of the
structures.
|
 |
Figure 5.
Figure 5. Overlay of the average NMR conformation of human
interferon α-2a (in orange) and the X-ray structure of murine
interferon-β (in cyan) [Senda et al 1995]. The α-helices are
marked with labels A to E close to their N-terminal end. The
Figure was prepared using the program Ribbons 2.0 [Carson 1991].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1997,
274,
661-675)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Yamaguchi,
Y.Hirakura,
H.Shirai,
H.Mimura,
and
T.Toyo'oka
(2011).
Quantitative evaluation of protein conformation in pharmaceuticals using cross-linking reactions coupled with LC-MS/MS analysis.
|
| |
J Pharm Biomed Anal,
55,
574-582.
|
 |
|
|
|
|
 |
T.Geppert,
B.Hoy,
S.Wessler,
and
G.Schneider
(2011).
Context-based identification of protein-protein interfaces and "hot-spot" residues.
|
| |
Chem Biol,
18,
344-353.
|
 |
|
|
|
|
 |
S.R.Akabayov,
Z.Biron,
P.Lamken,
J.Piehler,
and
J.Anglister
(2010).
NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.
|
| |
Biochemistry,
49,
687-695.
|
 |
|
|
|
|
 |
V.Oganesyan,
M.M.Damschroder,
K.E.Cook,
H.Wu,
and
W.F.Dall'acqua
(2009).
Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-interferon antibody fragment and human interferon alpha-2A.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
65,
14-16.
|
 |
|
|
|
|
 |
J.Y.Chang
(2008).
Diversity of folding pathways and folding models of disulfide proteins.
|
| |
Antioxid Redox Signal,
10,
171-178.
|
 |
|
|
|
|
 |
Z.Li,
J.J.Strunk,
P.Lamken,
J.Piehler,
and
T.Walz
(2008).
The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.
|
| |
J Mol Biol,
377,
715-724.
|
 |
|
|
|
|
 |
E.Kalie,
D.A.Jaitin,
R.Abramovich,
and
G.Schreiber
(2007).
An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities.
|
| |
J Biol Chem,
282,
11602-11611.
|
 |
|
|
|
|
 |
G.Vitale,
C.H.van Eijck,
P.M.van Koetsveld Ing,
J.I.Erdmann,
E.J.Speel,
K.van der Wansem Ing,
D.M.Mooij,
A.Colao,
G.Lombardi,
E.Croze,
S.W.Lamberts,
and
L.J.Hofland
(2007).
Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.
|
| |
Ann Surg,
246,
259-268.
|
 |
|
|
|
|
 |
H.H.Kim,
Y.M.Lee,
J.K.Suh,
and
N.W.Song
(2007).
Photodegradation mechanism and reaction kinetics of recombinant human interferon-alpha2a.
|
| |
Photochem Photobiol Sci,
6,
171-180.
|
 |
|
|
|
|
 |
S.Pestka
(2007).
The interferons: 50 years after their discovery, there is much more to learn.
|
| |
J Biol Chem,
282,
20047-20051.
|
 |
|
|
|
|
 |
C.Sommereyns,
and
T.Michiels
(2006).
N-glycosylation of murine IFN-beta in a putative receptor-binding region.
|
| |
J Interferon Cytokine Res,
26,
406-413.
|
 |
|
|
|
|
 |
H.Schmeisser,
P.Kontsek,
D.Esposito,
W.Gillette,
G.Schreiber,
and
K.C.Zoon
(2006).
Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag.
|
| |
J Interferon Cytokine Res,
26,
866-876.
|
 |
|
|
|
|
 |
S.R.Quadt-Akabayov,
J.H.Chill,
R.Levy,
N.Kessler,
and
J.Anglister
(2006).
Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.
|
| |
Protein Sci,
15,
2656-2668.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Grace,
S.Lee,
S.Bradshaw,
J.Chapman,
J.Spond,
S.Cox,
M.Delorenzo,
D.Brassard,
D.Wylie,
S.Cannon-Carlson,
C.Cullen,
S.Indelicato,
M.Voloch,
and
R.Bordens
(2005).
Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.
|
| |
J Biol Chem,
280,
6327-6336.
|
 |
|
|
|
|
 |
S.Pestka,
C.D.Krause,
D.Sarkar,
M.R.Walter,
Y.Shi,
and
P.B.Fisher
(2004).
Interleukin-10 and related cytokines and receptors.
|
| |
Annu Rev Immunol,
22,
929-979.
|
 |
|
|
|
|
 |
S.Pestka,
C.D.Krause,
and
M.R.Walter
(2004).
Interferons, interferon-like cytokines, and their receptors.
|
| |
Immunol Rev,
202,
8.
|
 |
|
|
|
|
 |
T.D.Jones,
M.Hanlon,
B.J.Smith,
C.T.Heise,
P.D.Nayee,
D.A.Sanders,
A.Hamilton,
C.Sweet,
E.Unitt,
G.Alexander,
K.M.Lo,
S.D.Gillies,
F.J.Carr,
and
M.P.Baker
(2004).
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection.
|
| |
J Interferon Cytokine Res,
24,
560-572.
|
 |
|
|
|
|
 |
T.Peleg-Shulman,
L.C.Roisman,
G.Zupkovitz,
and
G.Schreiber
(2004).
Optimizing the binding affinity of a carrier protein: a case study on the interaction between soluble ifnar2 and interferon beta.
|
| |
J Biol Chem,
279,
18046-18053.
|
 |
|
|
|
|
 |
D.Platis,
and
G.R.Foster
(2003).
Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
|
| |
J Interferon Cytokine Res,
23,
655-666.
|
 |
|
|
|
|
 |
J.H.Chill,
S.R.Quadt,
R.Levy,
G.Schreiber,
and
J.Anglister
(2003).
The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding.
|
| |
Structure,
11,
791-802.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.K.Sharma,
and
D.S.Kalonia
(2003).
Steady-state tryptophan fluorescence spectroscopy study to probe tertiary structure of proteins in solid powders.
|
| |
J Pharm Sci,
92,
890-899.
|
 |
|
|
|
|
 |
V.Salucci,
M.Lu,
L.Aurisicchio,
N.La Monica,
M.Roggendorf,
and
F.Palombo
(2002).
Expression of a new woodchuck IFN-alpha gene by a helper-dependent adenoviral vector in woodchuck hepatitis virus-infected primary hepatocytes.
|
| |
J Interferon Cytokine Res,
22,
1027-1034.
|
 |
|
|
|
|
 |
Y.S.Wang,
S.Youngster,
M.Grace,
J.Bausch,
R.Bordens,
and
D.F.Wyss
(2002).
Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.
|
| |
Adv Drug Deliv Rev,
54,
547-570.
|
 |
|
|
|
|
 |
L.C.Roisman,
J.Piehler,
J.Y.Trosset,
H.A.Scheraga,
and
G.Schreiber
(2001).
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking.
|
| |
Proc Natl Acad Sci U S A,
98,
13231-13236.
|
 |
|
|
|
|
 |
S.Sun,
W.Mo,
Y.Ji,
and
S.Liu
(2001).
Use of nitrocellulose films for affinity-directed mass spectrometry for the analysis of antibody/antigen interactions.
|
| |
Rapid Commun Mass Spectrom,
15,
1743-1746.
|
 |
|
|
|
|
 |
V.C.Blank,
C.Peña,
and
L.P.Roguin
(2000).
Suitable experimental conditions are required to characterize interferon-alpha2b synthetic peptides.
|
| |
Eur J Biochem,
267,
5711-5716.
|
 |
|
|
|
|
 |
K.E.Mogensen,
M.Lewerenz,
J.Reboul,
G.Lutfalla,
and
G.Uzé
(1999).
The type I interferon receptor: structure, function, and evolution of a family business.
|
| |
J Interferon Cytokine Res,
19,
1069-1098.
|
 |
|
|
|
|
 |
R.M.Arduini,
K.L.Strauch,
L.A.Runkel,
M.M.Carlson,
X.Hronowski,
S.F.Foley,
C.N.Young,
W.Cheng,
P.S.Hochman,
and
D.P.Baker
(1999).
Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
|
| |
Protein Sci,
8,
1867-1877.
|
 |
|
|
|
|
 |
V.C.Blank,
A.Sterin-Prync,
L.Retegui,
A.Vidal,
M.Criscuolo,
and
L.P.Roguin
(1999).
Identification of a linear epitope of interferon-alpha2b recognized by neutralizing monoclonal antibodies.
|
| |
Eur J Biochem,
265,
11-19.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |